The European Medicines Agency (EMA) is still considering the approval of Hipra's SARS-CoV-2 vaccine. In mid-May, Hipra said it was ready to "have the vaccine available in a few days" following EMA approval, which it expected by the middle of this year, but which is being delayed until at least after July, as Elia Torroella, Hipra's R&D and Registration Director, explained at a breakfast briefing organised by the company today.
US researchers have designed an intranasal vaccination device that is capable of delivering immunising proteins through the mucosal surface. The research, published in Science Translational Medicine, shows that strong antibody responses against viruses such as HIV and SARS-CoV-2 have been achieved in mice and non-human primates.
Results from a survey of more than 39,000 menstruating individuals reveal that 42% experienced heavier bleeding after SARS-CoV-2 vaccination. Among the most likely groups were pre-menopausal women, Hispanic or Latina women, those who had been pregnant, and those with conditions such as endometriosis and polycystic ovary syndrome.
Según datos de la OMS y UNICEF, 25 millones de niños no han recibido sus vacunas contra la difteria, el tétanos y la tosferina (DTP) a nivel global. Se trata de la mayor caída continuada en cobertura vacunal en casi treinta años.
The Minister of Health, Carolina Darias, announced in an interview on La Sexta that there will be a fourth dose of the covid-19 vaccine "for the entire population".
In a press release published this week, Moderna has shared the first data on its new bivalent adapted vaccine against Omicron.
A paper published today in the journal Circulation concludes that acute myocarditis is a rare complication in patients hospitalised with covid-19 and that the severity of its prognosis depends on the simultaneous presence of pneumonia.
The European Medicines Agency (EMA) and the European Centre for Disease Prevention and Control (ECDC) consider it too early for the general population to receive a fourth dose of covid-19 mRNA vaccines. Both agencies do agree that people over 80 years of age should receive it because of their increased risk of severe disease.
Two studies published in The Lancet Infectious Diseases confirm that covid-19 vaccines offer additional protection for those already infected with SARS-CoV-2, especially against severe disease.
Reporting on vaccines is not easy, but in recent years many journalists have had to navigate studies and reports full of new terminology and concepts. In this guide, we attempt to clarify some of the most important points for accurate reporting on these medicines.